vTv Therapeutics

-$0.0213 (-4.48%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VTVT and other ETFs, options, and stocks.

About VTVT

vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer.

CEO
Richard S. Nelson
Employees
9
Headquarters
High Point, North Carolina
Founded
2015

VTVT Key Statistics

Market cap
40.42M
Price-Earnings ratio
—
Dividend yield
—
Average volume
337.43K
High today
$0.5421
Low today
$0.424
Open price
$0.47
Volume
202.62K
52 Week high
$2.88
52 Week low
$0.382

VTVT Earnings

-$0.11
-$0.07
-$0.02
$0.02
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.08 per share
Actual
-$0.10 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure